AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49
DOES HIV-INFECTION AGGRAVATE CHRONIC HEPATITIS-C IN IV DRUG-USERS - ACASE-CONTROL STUDY
Authors: SERFATY L COSTAGLIOLA D WENDUM D PICARD O MEYOHAS MC GIRARD PM LEBAS J DELAMARE DC POUPON R HOUSSET C
Citation: L. Serfaty et al., DOES HIV-INFECTION AGGRAVATE CHRONIC HEPATITIS-C IN IV DRUG-USERS - ACASE-CONTROL STUDY, Hepatology, 28(4), 1998, pp. 1199-1199
PREVALENCE AND COLORECTAL CHARACTERISTICS OF COLORECTAL ADENOMAS IN PATIENTS TREATED WITH URSODESOXYCHOLIC ACID FOR PRIMARY BILIARY-CIRRHOSIS - A CASE-CONTROL STUDY
Authors: SERFATY L LORIA A CHAZOUILLERES O CHRETIEN Y POUPON RE POUPON R
Citation: L. Serfaty et al., PREVALENCE AND COLORECTAL CHARACTERISTICS OF COLORECTAL ADENOMAS IN PATIENTS TREATED WITH URSODESOXYCHOLIC ACID FOR PRIMARY BILIARY-CIRRHOSIS - A CASE-CONTROL STUDY, Hepatology, 28(4), 1998, pp. 1527-1527
PRIMARY BILIARY-CIRRHOSIS AUTOIMMUNE HEPATITIS OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY
Authors: CHAZOUILLERES O WENDUM D SERFATY L MONTEMBAULT S ROSMORDUC O POUPON R
Citation: O. Chazouilleres et al., PRIMARY BILIARY-CIRRHOSIS AUTOIMMUNE HEPATITIS OVERLAP SYNDROME - CLINICAL-FEATURES AND RESPONSE TO THERAPY, Hepatology, 28(2), 1998, pp. 296-301
DETERMINANTS OF OUTCOME OF COMPENSATED HEPATITIS-C VIRUS-RELATED CIRRHOSIS
Authors: SERFATY L AUMAITRE H CHAZOUILLERES O BONNAND AM ROSMORDUC O POUPON RE POUPON R
Citation: L. Serfaty et al., DETERMINANTS OF OUTCOME OF COMPENSATED HEPATITIS-C VIRUS-RELATED CIRRHOSIS, Hepatology, 27(5), 1998, pp. 1435-1440
CONSENSUS CONFERENCE ON SCREENING AND TRE ATMENT OF HEPATITIS-C
Authors: DHUMEAUX D DOFFOEL M BEDOSSA P BIGARD MA BISMUTH H CACOUB P CARPENTIER F COUROUCE AM DUROCHER A GALMICHE JP GOUDEAU A HILLON P MARCELLIN P OULDAOUDIA V PHAM BN RAGUIN G AUBREGE A ASSIE P CARO D CHAVANET P COLOMB M DUCROTTE P FRANCO D GORDIN J GOUILLOUD S HAMMEL JP HUGUET C PARIENTE A REVEL M RICHARD S SALAMON R WORONOFFLEMSI MC BRECHOT C BRISSOT P COUZIGOU P DEGOS F DESENCLOS JC DEUGNIER Y DURAND JM LARREY D LUNELFABIANI F MARCELLIN P MIGUET JM MOATTI JP PASCAL JP PAWLOTSKY JM POUPON R POYNARD T TREPO C ZARSKI JP MUSSET L PEREZ P TRAN A SERFATY L PAYEN JL OUZAN D
Citation: D. Dhumeaux et al., CONSENSUS CONFERENCE ON SCREENING AND TRE ATMENT OF HEPATITIS-C, La Presse medicale, 26(3), 1997, pp. 126-128
RESULTS OF HEPATITIS-C TREATMENT WITH INT ERFERON ALONE OR ASSOCIATEDWITH OTHER DRUGS
Authors: SERFATY L
Citation: L. Serfaty, RESULTS OF HEPATITIS-C TREATMENT WITH INT ERFERON ALONE OR ASSOCIATEDWITH OTHER DRUGS, Gastroenterologie clinique et biologique, 21(1BIS), 1997, pp. 154-166
SEVERE INFECTION WITH FASCIOLA-HEPATICA A S THE CAUSE OF HEMORRHAGIC ASCITES
Authors: MONTEMBAULT S SERFATY L POIROT JL WENDUM D PENNA C POUPON R
Citation: S. Montembault et al., SEVERE INFECTION WITH FASCIOLA-HEPATICA A S THE CAUSE OF HEMORRHAGIC ASCITES, Gastroenterologie clinique et biologique, 21(10), 1997, pp. 785-788
RISK-FACTORS FOR CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION - RESULTS OF A CASE-CONTROL STUDY
Authors: SERFATY L CHAZOUILLERES O POUJOLROBERT A MORANDJOUBERT L DUBOIS C CHRETIEN Y POUPON RE PETIT JC POUPON R
Citation: L. Serfaty et al., RISK-FACTORS FOR CIRRHOSIS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION - RESULTS OF A CASE-CONTROL STUDY, Hepatology, 26(3), 1997, pp. 776-779
EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS
Authors: ROUDOTTHORAVAL F BASTIE A PAWLOTSKY JM DHUMEAUX D AUDIGIER JC BARBARE JC BAUDET JG BEAUGRAND M BERTHELOT P BRECHOT C POL S CATTAN D BETTAN L CHAPUT JC COUZIGOU P DAO MT DENIS J DOFFOEL M DRUCKER J ERLINGER S MARCELLIN P ETIENNE JP BUFFET C LAURENTPUIG P FILOCHE B GAUCHER P GAUTHIER A DELREZ R INK O METMAN E BACQ Y MICHEL H LARREY D MIGUET JP BRESSONHADNI S MORICHAUBEAUCHANT M OPOLON P POYNARD T PASCAL JP PAYEN JL POUPON R SERFATY L SONDAG D TERRIS G TREPO C AHMED SNS WAGNER JC ZARSKI JP MAYNARD M
Citation: F. Roudotthoraval et al., EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS, Hepatology, 26(2), 1997, pp. 485-490
EVIDENCE FOR A DEFICIENCY OF INTERFERON RESPONSE IN MONONUCLEAR-CELLSFROM HEPATITIS-C VIREMIC PATIENTS
Authors: PODEVIN P GUECHOT J SERFATY L MONRANDJOUBERT L VEYRUNES C BONNEFIS MT POUPON R
Citation: P. Podevin et al., EVIDENCE FOR A DEFICIENCY OF INTERFERON RESPONSE IN MONONUCLEAR-CELLSFROM HEPATITIS-C VIREMIC PATIENTS, Journal of hepatology, 27(2), 1997, pp. 265-271
PROPHYLAXIS AND TREATMENT OF HEPATITIS-C
Authors: POUPON R SERFATY L
Citation: R. Poupon et L. Serfaty, PROPHYLAXIS AND TREATMENT OF HEPATITIS-C, Annales de Gastroenterologie et d'Hepatologie, 33(1), 1997, pp. 34-38
HEPATITIS-C - SCREENING AND MANAGEMENT
Authors: GALMICHE JP AUBREGE A ASSIE P CARO D CHAVANET P COLOMB M DUCROTTE P FRANCO D GORDIN J GOUILLOUD S HAMMEL JP HUGUET C PARIENTE A REVEL M RICHARD S SALAMON R WORONOFFLEMSI MC BRECHOT C BRISSOT P COUZIGOU P DEGOS F DESENCLOS JC DEUGNIER Y DURAND JM LARREY D LUNELFABIANI F MARCELLIN P MIGUET JP MOATTI JP PASCAL JP PAWLOTSKY JM POUPON R POYNARD T TREPO C ZARSKI JP MUSSET L PEREZ P TRAN A SERFATY L PAYEN JL OUZAN D
Citation: Jp. Galmiche et al., HEPATITIS-C - SCREENING AND MANAGEMENT, La Semaine des hopitaux de Paris, 73(13-14), 1997, pp. 393-398
RISK-FACTORS FOR LIVER-CIRRHOSIS OCCURRENCE IN PATIENTS WITH CHRONIC HCV INFECTION - A CASE-CONTROL STUDY
Authors: SERFATY L POUJOL A CHAZOUILLERES O DUBOIS C MORANDJOUBERT L CHRETIEN Y POUPON RE POUPON R
Citation: L. Serfaty et al., RISK-FACTORS FOR LIVER-CIRRHOSIS OCCURRENCE IN PATIENTS WITH CHRONIC HCV INFECTION - A CASE-CONTROL STUDY, Hepatology, 24(4), 1996, pp. 98-98
LONG-TERM FOLLOW-UP OF HCV COMPENSATED CIRRHOSIS
Authors: SERFATY L AUMAITRE H CHAZOUILLERES O MORANDJOUBERT L PETIT JC POUPON R
Citation: L. Serfaty et al., LONG-TERM FOLLOW-UP OF HCV COMPENSATED CIRRHOSIS, Hepatology, 24(4), 1996, pp. 501-501
PROGNOSTIC VALUE OF SERUM HYALURONAN LEVELS INPATIENTS WITH HCV COMPENSATED CIRRHOSIS
Authors: GUECHOT J SERFATY L POUPON R GIBOUDEAU J
Citation: J. Guechot et al., PROGNOSTIC VALUE OF SERUM HYALURONAN LEVELS INPATIENTS WITH HCV COMPENSATED CIRRHOSIS, Hepatology, 24(4), 1996, pp. 1067-1067
INTERFERON-ALFA AND URSODEOXYCHOLIC ACID COMBINATION VERSUS INTERFERON ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED TRIAL
Authors: BONNAND AM POUPON R QUENEAU PE TREPO C COHARD M VETTER D RAABE JJ LAMEY D GRANGE JD CAPRON JP SERFATY L CHRETIEN Y SAINTMARCGIRARDIN MF MATHIEXFORTUNET H ZAFRANI ES POUPON RE
Citation: Am. Bonnand et al., INTERFERON-ALFA AND URSODEOXYCHOLIC ACID COMBINATION VERSUS INTERFERON ALONE IN THE TREATMENT OF CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED TRIAL, Hepatology, 24(4), 1996, pp. 1107-1107
IS GB-VIRUS-C (GBV-C) THE CAUSE OF CRYPTOGENETIC CHRONIC LIVER-DISEASE
Authors: SERFATY L PAWLOTSKY JM GERMANIDIS G CHAZOUILLERES O PILON A POUPON R
Citation: L. Serfaty et al., IS GB-VIRUS-C (GBV-C) THE CAUSE OF CRYPTOGENETIC CHRONIC LIVER-DISEASE, Hepatology, 24(4), 1996, pp. 1802-1802
PLASMA PI-GLUTATHIONE S-TRANSFERASE AS A MARKER OF BILIARY CELL-DAMAGE
Authors: VAUBOURDOLLE M CHAZOUILLERES O LASNIER E SERFATY L GIBOUDEAU J POUPON R
Citation: M. Vaubourdolle et al., PLASMA PI-GLUTATHIONE S-TRANSFERASE AS A MARKER OF BILIARY CELL-DAMAGE, Hepatology, 24(4), 1996, pp. 1868-1868
ANTIACTIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: CHAZOUILLERES O JOHANET C SERFATY L CARBONNEL F SMADJA M NAUDIN G DUBEL L POUPON R
Citation: O. Chazouilleres et al., ANTIACTIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of hepatology, 24(4), 1996, pp. 513-513
VITAMIN-K1 THERAPY FOR HEPATOCELLULAR-CARCINOMA - RESULTS OF A PROSPECTIVE OPEN STUDY
Authors: AUMAITRE H CHAZOUILLERES O SERFATY L ROBERT A POUPON R
Citation: H. Aumaitre et al., VITAMIN-K1 THERAPY FOR HEPATOCELLULAR-CARCINOMA - RESULTS OF A PROSPECTIVE OPEN STUDY, Gastroenterology, 110(4), 1996, pp. 1145-1145
PLASMA-CONCENTRATION OF REDUCED GLUTATHIONE (GSH) AND RESPONSE TO INTERFERON (IFN) IN PATIENTS WITH CHRONIC HEPATITIS-C
Authors: CHAZOUILLERES O VAUBOURDOLLE M SABBAH I SERFATY L GIBOUDEAU J POUPON R
Citation: O. Chazouilleres et al., PLASMA-CONCENTRATION OF REDUCED GLUTATHIONE (GSH) AND RESPONSE TO INTERFERON (IFN) IN PATIENTS WITH CHRONIC HEPATITIS-C, Gastroenterology, 110(4), 1996, pp. 1167-1167
HOW DO PATIENTS WITH MILD CHRONIC HEPATITIS-C RESPOND TO INTERFERON (IFN) THERAPY
Authors: CHAZOUILLERES O SERFATY L DAUCHOT JM LORIA A LEGENDRE C POUPON R
Citation: O. Chazouilleres et al., HOW DO PATIENTS WITH MILD CHRONIC HEPATITIS-C RESPOND TO INTERFERON (IFN) THERAPY, Gastroenterology, 110(4), 1996, pp. 1167-1167
ALPHA-GLUTATHIONE S-TRANSFERASE (ALPHA-GST) PLASMA DETERMINATION IN THE FOLLOW-UP OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C
Authors: VAUBOURDOLLE M CHAZOUILLERES O SERFATY L OKANDZE A POUPON R GIBOUDEAU M
Citation: M. Vaubourdolle et al., ALPHA-GLUTATHIONE S-TRANSFERASE (ALPHA-GST) PLASMA DETERMINATION IN THE FOLLOW-UP OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C, Gastroenterology, 110(4), 1996, pp. 1353-1353
INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY
Authors: SERFATY L CHAZOUILLERES O PAWLOTSKY JM ANDREANI T PELLET C POUPON R
Citation: L. Serfaty et al., INTERFERON-ALFA THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C AND PERSISTENTLY NORMAL AMINOTRANSFERASE ACTIVITY, Gastroenterology, 110(1), 1996, pp. 291-295
DIAGNOSTIC-ACCURACY OF HYALURONAN AND TYPE-III PROCOLLAGEN AMINO-TERMINAL PEPTIDE SERUM ASSAYS AS MARKERS OF LIVER FIBROSIS IN CHRONIC VIRAL-HEPATITIS-C EVALUATED BY ROC CURVE ANALYSIS
Authors: GUECHOT J LAUDAT A LORIA A SERFATY L POUPON R GIBOUDEAU J
Citation: J. Guechot et al., DIAGNOSTIC-ACCURACY OF HYALURONAN AND TYPE-III PROCOLLAGEN AMINO-TERMINAL PEPTIDE SERUM ASSAYS AS MARKERS OF LIVER FIBROSIS IN CHRONIC VIRAL-HEPATITIS-C EVALUATED BY ROC CURVE ANALYSIS, Clinical chemistry, 42(4), 1996, pp. 558-563
Risultati: 1-25 | 26-49